294 related articles for article (PubMed ID: 30527251)
21. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
22. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of the 8
Ito Y; Miyauchi A; Hirokawa M; Yamamoto M; Oda H; Masuoka H; Sasai H; Fukushima M; Higashiyama T; Kihara M; Miya A
Endocr J; 2018 Jun; 65(6):621-627. PubMed ID: 29618671
[TBL] [Abstract][Full Text] [Related]
24. Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study.
Jin M; Kim ES; Kim BH; Kim HK; Yi HS; Jeon MJ; Kim TY; Kang HC; Kim WB; Shong YK; Kim M; Kim WG
Endocrinol Metab (Seoul); 2020 Sep; 35(3):618-627. PubMed ID: 32981304
[TBL] [Abstract][Full Text] [Related]
25. Hemithyroidectomy for low-risk follicular carcinoma of the thyroid: results from a regional hospital.
Chow TL; Tam SW; Choi CY; Kwan WW
Singapore Med J; 2018 Jun; 59(6):311-315. PubMed ID: 29214321
[TBL] [Abstract][Full Text] [Related]
26. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
28. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
30. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
Wong RM; Bresee C; Braunstein GD
Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
[TBL] [Abstract][Full Text] [Related]
31. Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
Bortz MD; Kuchta K; Winchester DJ; Prinz RA; Moo-Young TA
Surgery; 2021 Jan; 169(1):2-6. PubMed ID: 32682508
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period.
Yu XF; Wang WB; Teng XD; Wang HY; Chen X; Wang HH; Ma ZM; Fahey TJ; Teng LS
Eur J Surg Oncol; 2014 Jul; 40(7):869-74. PubMed ID: 24613740
[TBL] [Abstract][Full Text] [Related]
33. Nomogram for Predicting Central Lymph Node Metastasis in Papillary Thyroid Cancer: A Retrospective Cohort Study of Two Clinical Centers.
Yang Z; Heng Y; Lin J; Lu C; Yu D; Tao L; Cai W
Cancer Res Treat; 2020 Oct; 52(4):1010-1018. PubMed ID: 32599980
[TBL] [Abstract][Full Text] [Related]
34. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study.
Yang Z; Heng Y; Zhao Q; Hao D; Tao L; Deng X; Cai W; Qiu W
Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212
[TBL] [Abstract][Full Text] [Related]
35. Subclassification of Tumor Extension and Nodal Metastasis in Papillary Thyroid Cancer to Improve Prognostic Accuracy of the Eighth Edition of the Tumor-Node-Metastasis Classification.
Ito Y; Miyauchi A; Kihara M; Masuoka H; Higashiyama T; Miya A
World J Surg; 2020 Feb; 44(2):336-345. PubMed ID: 31428837
[TBL] [Abstract][Full Text] [Related]
36. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
Li W; Tang Y; Li J; Han W; Wang D; Wang Y
Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
[TBL] [Abstract][Full Text] [Related]
37. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
38. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
39. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
Kim M; Jeon MJ; Oh HS; Park S; Song DE; Sung TY; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
Thyroid; 2018 Apr; 28(4):496-503. PubMed ID: 29620964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]